UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934
Date
of Report (Date of earliest event reported): February 11, 2008
| |
| SAFESTITCH MEDICAL, INC. |
| |
| (Exact Name of Registrant as Specified in Its Charter) |
| |
|
|
|
|
| Delaware
|
|
0-19437
|
|
11-2962080 |
|
|
|
|
|
|
(State or Other Jurisdiction of
Incorporation)
|
|
(Commission File
Number)
|
|
(IRS Employer
Identification No.) |
| |
4400 Biscayne Boulevard
Suite 980
Miami, Florida 33137 |
| |
| (Address of Principal Executive Office) |
Registrant’s telephone number, including area code (305) 575-6000
| |
| |
| |
| (Former Name or Former Address, if Changed Since Last Report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
| |
|
|
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
|
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
|
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
|
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
|
|
|
| Item 7.01 |
|
Regulation FD Disclosure |
On
February 11, 2008, SafeStitch Medical, Inc., a Delaware corporation (the “Company”), issued
a press release announcing that its trading symbol on the OTCBB will change from “CTSC” to “SFES”,
effective Monday, February 11, 2008. The new symbol has been issued in connection with the
Company’s name change from Cellular Technical Services Company, Inc. to SafeStitch Medical, Inc.
Additionally, the press release includes the web address for the Company’s new website at
www.safestitch.com. A copy of the press release is furnished as Exhibit 99.1 to this Current
Report on Form 8-K and is incorporated by reference herein.
The press release attached as an exhibit to this report contains various “forward looking
statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended, which represent the Company’s
expectations or beliefs concerning future events. When used in the press release and this report,
the terms “anticipate,” “believe,” “estimate,” “expect” and “intend” and words or phrases of
similar import, as they relate to the Company or its subsidiaries or its management, are intended
to identify forward-looking statements. These forward-looking statements are further qualified by
important factors that could cause actual results to differ materially from those in the
forward-looking statements. These factors include, without limitation, the Company’s ability to
protect its intellectual property, dedication of substantial resources towards research and
development efforts, product liability risks and the effects of governmental regulation. Results
actually achieved may differ materially from expected results included in these statements as a
result of these or other factors, including those factors discussed under “Risk Factors” set forth
in Item 1A of the Form 10 disclosures contained in the Company’s Current Report on Form 8-K filed
with the Securities and Exchange Commission on September 10, 2007. The Company undertakes no
obligation to update, and the Company does not have a policy of updating or revising, these
forward-looking statements.
The information in this report will not be deemed an admission as to the materiality of any
information required to be disclosed solely to satisfy the requirements of Regulation FD. The
furnishing of this information is not intended to, and does not, constitute a determination or
admission by the Company that such information is material or complete, or that investors should
consider this information before making an investment decision with respect to any security of the
Company.
The information contained in Item 7.01 to this Current Report on Form 8-K and Exhibit 99.1
attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange
Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be
deemed incorporated by reference in any filing by the Company under the Securities Act of 1933, as
amended.
|
|
|
| Item 9.01. |
|
Financial Statements and Exhibits |
| |
|
|
|
|
| Exhibit |
|
|
| Number |
|
Description |
| |
|
|
|
|
| |
99.1 |
|
|
Press
Release issued by the Company on February 11, 2008. |